Managers

Asian VC industry more than doubled in three years

IntelyCare snags $10.8 mln Series A

Boston-based IntelyCare, an on-demand healthcare staffing solution for skilled nursing facilities and assisted living centers, has secured $10.8 million in Series A funding. Leerink Revelation Partners led the round with participation from Longmeadow Capital, LRVHealth and Bill Mantzoukas.

Social Capital claims a cumulative net IRR of 18.6 percent

Biotech IPOs stride along

Biotech’s excesses trouble investors

VC-backed Orchard Therapeutics goes public

Orchard Therapeutics, a gene therapy developer, has raised $200 million for its IPO after pricing its 14.3 shares at $14 per share. The stock began trading October 31, 2018 on the NASDAQ under the ticker symbol "ORTX." J.P. Morgan, Goldman Sachs and Cowen are the lead underwriters. Orchard's pre-IPO backers include Baillie Gifford, ORI Capital, Temasek and Cowen Healthcare.

1DROP snags $4.25 mln Series A

Boston and Switzerland-based 1DROP, a developer of a medical diagnostic testing platform, has secured $4.25 million in Series A financing. Christian Wildmoser, a former partner at CVC Capital Partners, led the transaction.

On the Bleeding Edge: Why Icon's expanded fund is a big deal

In Israel, larger is better as Q3 seed investing drops: report

Fenox and Sega Sammy roll out $20 mln venture fund

Silicon Valley-based venture firm Fenox Venture Capital and Japanese general entertainment company Sega Sammy Holdings have launched a $20 million venture fund. The fund invests in advanced technologies.